BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 14 analysts with an average price target of $49.3. This is a potential upside of $24.01 (94.94%) from yesterday's end of day stock price of $25.29.

Beam Therapeutics 's activity chart (see below) currently has 40 price targets and 60 ratings on display. The stock rating distribution of BEAM is 55.88% BUY and 44.12% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.02% with an average time for these price targets to be met of 78.08 days.

Highest price target for BEAM is $78, Lowest price target is $24, average price target is $49.3.

Most recent stock forecast was given by RICK BIENKOWSKI from CANTOR FITZGERALD on 06-Nov-2024. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 19 are a BUY (55.88%), 15 are a HOLD (44.12%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$39

$14.95 (62.16%)

$32

14 days ago
(06-Nov-2024)

1/10 (10%)

$12.36 (46.40%)

118

Hold

$24

$-0.05 (-0.21%)

$27

14 days ago
(06-Nov-2024)

5/6 (83.33%)

$-2.64 (-9.91%)

83

Hold

$24

$-0.05 (-0.21%)

$35

1 months 4 days ago
(16-Oct-2024)

2/4 (50%)

$-2.69 (-10.08%)

38

Buy

$69

$44.95 (186.90%)

$66

2 months 9 days ago
(11-Sep-2024)

0/3 (0%)

$44.88 (186.07%)

Buy

$48

$23.95 (99.58%)

$40

3 months 13 days ago
(07-Aug-2024)

3/6 (50%)

$23.54 (96.24%)

237

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 78.08 days on average for the stock forecasts to be realized with a an average price target met ratio 39.02

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 7 price targets and 6 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Yanan Zhu with highest potential upside - $80.95

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Greg Harrison with lowest potential downside - -$0.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?